At ThinWorks in Palm Beach Gardens, Florida, our medically supervised peptide programs are built around personalized protocols, not generic dosing charts
This protocol maintains copper supplementation supporting collagen synthesis without full daily intensity, potentially sustaining 60-80% of peak benefits at 50-70% of continuous use cost while avoiding complete benefit decline from full discontinuation
Drinking water kefir has also been associated with the potential of controlling cholesterol level
Lilly leads with retatrutide and orforglipron, while Novo has CagriSema, Amycretin, and oral semaglutide
The Revita clinical profile in this study suggests we have the potential to create a new standard of care in obesity with a disease-modifying intervention that allows us to progress from chasing weight loss to sustaining health with a durable metabolic reset. Upcoming Milestones The REMAIN-1 Midpoint Cohort is ongoing, with 6-month data expected in Q1 2026
Understanding GLP-1 Medications GLP-1 (glucagon-like peptide-1) medications are a revolutionary approach in the fight against insulin resistance-based weight problems